# Study In Patients With Insulin Resistance

> **NCT00197132** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 18 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Avandia

## Key facts

- **NCT ID:** NCT00197132
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197132, "Study In Patients With Insulin Resistance". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00197132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*